Feb 17, 2026 08:30AM
Feb 5, 2026 04:05PM
Jan 7, 2026 07:32AM
Jan 7, 2026 07:30AM
Jan 5, 2026 07:30AM
Jan 5, 2026 07:30AM
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Dec 21, 2025 04:00AM
Dec 19, 2025 09:06AM
Dec 2, 2025 07:30AM
Dec 2, 2025 07:30AM
Nov 25, 2025 04:00PM
Nov 19, 2025 09:14AM
Nov 19, 2025 09:06AM Arrowhead Pharma (ARWR) PT Raised at RBC Capital Following Redemplo Approval
Nov 19, 2025 08:51AM
Nov 18, 2025 11:52AM
Nov 18, 2025 11:52AM
Nov 18, 2025 11:17AM
Oct 24, 2025 08:29AM
Sep 11, 2025 07:30AM
Sep 11, 2025 07:30AM Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals
Aug 7, 2025 04:01PM
Aug 1, 2025 06:30AM
Aug 1, 2025 06:30AM
Jun 23, 2025 07:30AM
May 13, 2025 04:52AM
May 12, 2025 04:01PM
Feb 10, 2025 04:01PM Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results
Jan 17, 2025 04:30PM
Jan 3, 2025 07:33AM
Dec 4, 2024 06:47AM
Nov 27, 2024 07:14AM
Nov 27, 2024 05:33AM
Nov 26, 2024 04:00PM
Nov 26, 2024 07:00AM Arrowhead Pharmaceuticals Announces Global License and Collaboration Agreement with Sarepta Therapeutics for Multiple Clinical and Preclinical Programs
Nov 18, 2024 01:58PM
Nov 18, 2024 07:31AM
Nov 18, 2024 07:31AM
Nov 18, 2024 07:31AM
Nov 18, 2024 07:30AM
Sep 10, 2024 07:30AM
Sep 10, 2024 07:30AM Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran
Sep 4, 2024 07:38AM
Sep 2, 2024 06:36AM
Aug 21, 2024 07:32AM
Aug 21, 2024 07:30AM
Jul 5, 2024 06:33AM
Jun 25, 2024 01:56PM
Jun 25, 2024 01:55PM Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial
Jun 3, 2024 07:32AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All